Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...

The conference brings together industry and academic professionals to explore the rapidly advancing science and business of mRNA medicines and features poster presentations highlighting the latest ...

Xenetic (XBIO) Biosciences announced the presentation of positive preclinical data. The poster titled, ” DNase I Targeting of Neutrophil Extracellular Traps Improves CTLA-4 Immune Checkpoint blockade ...

“We were pleased to report initial safety and efficacy data from twelve patients with advanced solid tumors enrolled in the Phase 2 part of the 065-101, proof of concept, clinical study of fadraciclib ...

November 12, 2024--(BUSINESS WIRE)--ENDRA Life ... today announced the acceptance of a poster titled "Noninvasive assessment of steatotic liver disease in individuals with class 2 and class 3 obesity" ...

FDA confirmed in a recent FDA Type B meeting under RMAT designation that the PROACT 1 Phase 3 study could be sufficient to support a full U.S. regulatory approval of rilparencelFDA also confirmed in ...

WALTHAM, Mass. and BOULDER, Colo., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined ...

Third Quarter, Recent Business Highlights and Upcoming Milestones Neurodegenerative ... has currently enrolled approximately 260 patients in the ASCENT clinical trials Poster presentation at CTAD 2024 ...

Their work tested use of this Microbix QAP with two commonly-used liquid media and six commercial and clinically-validated HPV assays. The results indicate that this QAP could be used for effective ...

The agreement enables ASTE, a pioneering healthcare distributor with over four decades of experience in Qatar, to address the high unmet need of DMD patients in the region. As the sole distributor of ...

Sunrise Life Celebrations is Toledo's newest locally owned funeral home, offering affordable, personalized cremation and funeral services. Focused on providing essential services without the high ...

Good afternoon, everyone, and welcome to Atea Pharmaceuticals third quarter 2024 financial results and business update conference call ... there are three poster presentations at AASLD, The Liver ...